Larimar Therapeutics
LRMR
LRMR
69 hedge funds and large institutions have $180M invested in Larimar Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 3 closing their positions.
Holders
69
Holders Change
+4
Holders Change %
+6.15%
% of All Funds
1.01%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
23
Reduced
25
Closed
3
Calls
$378K
Puts
$83K
Net Calls
+$295K
Net Calls Change
+$177K
Top Buyers
1 |
BOCH
1
Blue Owl Capital Holdings
New York
|
$15.5M |
2 |
SC
2
Stempoint Capital
New York
|
$3.56M |
3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.24M |
4 |
4
Janus Henderson Group
London,
United Kingdom
|
$12M |
5 |
5
BlackRock
New York
|
$7.59M |
Top Sellers
1 |
1
Citadel Advisors
Miami,
Florida
|
$3.1M |
2 |
OM
2
Opaleye Management
Boston,
Massachusetts
|
$2.84M |
3 |
3
Walleye Capital
New York
|
$266K |
4 |
4
Verition Fund Management
Greenwich,
Connecticut
|
$12.8M |
5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$2.74M |